Prenatal Screening and Diagnostic Testing
ClariTest™ Non-Invasive Prenatal Screening (NIPS)
ClariTest™ harnesses the power of massively parallel sequencing to screen for the most common fetal aneuploidies and specific microdeletion syndromes using a blood sample collected as early as 10 weeks. Learn more about ClariTest™.
Maternal Serum Screening
GenPath offerings include a number of blood tests that can provide a risk assessment for Down syndrome, trisomy 18, and open neural tube defects (ONTDs) that affect a pregnancy. Learn more about maternal serum screening.
Prenatal Diagnostic Testing
GenPath offers many different prenatal diagnostic tests performed on chorionic villus sampling (CVS) and amniocentesis samples. Learn more about prenatal diagnostic testing.